Allspring Global Investments Holdings, LLC Exagen Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$4.18 - $7.74 $21,924 - $40,596	-5,245 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$7.12 - $11.06 $15,870 - $24,652	2,229 Added 73.91%	5,245 $42,000
Q4 2021 Jan 28, 2022	BUY	$8.97 - $14.08 $27,053 - $42,465	3,016 New	3,016 $35,000

Others Institutions Holding XGN

# of Institutions

Shares Held

6.41M

Call Options Held

4.5K

Put Options Held

400

Rtw Investments, LP New York, NY

1.51M
Shares

$8.35 Million
0.07% of portfolio
Cowen And Company, LLC

891K
Shares

$4.92 Million
0.07% of portfolio
Silvercrest Asset Management Group LLC New York, NY

541K
Shares

$2.99 Million
0.01% of portfolio
Stonepine Capital Management, LLC Bend, OR

534K
Shares

$2.95 Million
1.04% of portfolio
Vanguard Group Inc Valley Forge, PA

491K
Shares

$2.71 Million
0.0% of portfolio

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account